Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.

By K. Marquis, R. Debigaré, Y. Lacasse, P. Leblanc, J. Jobin, G. Carrier, F. Maltais. American Journal of Respiratory and Critical Care Medicine, 2002

850 citations recorded by the source corpus.

Subfields: Physiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/f3d00db9dfeb4dd6b28a28812e7489fa260d7daa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

1. B. Saltin
2. B. K. Pedersen
3. Børge G. Nordestgaard
4. D. Parums
5. M. C. Severinsen
6. Haiming Cao

In Pulmonary and Respiratory Medicine

1. Jorgen Vestbo
2. Børge G. Nordestgaard
3. Bartolome Celli
4. B. K. Pedersen
5. D. Parums

Citations in the corpus

• American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. (2006, methodology): “Because the midthigh muscle cross-sectional area (using computed tomography scanning) in severe COPD was demonstrated to be a better indicator of prognosis than BMI (176), the loss of muscle mass rather than body weight may be a better predictor of mortality.”
• Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. (2005, methodology): “measured in a lung function laboratory (11, 34).”
• Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases (2015, background): “Moreover, low muscle mass is associated with increased risk of mortality (Marquis et al., 2002).”
• Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. (2006, result): “Support for this comes from a study by Marquis and coworkers (12) showing midthigh muscle cross-sectional area to be a better predictor of mortality than BMI and from a recent study by Bolton and colleagues (13) showing that loss of FFM was associated with loss of bone mineral density and frank oste”
• Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease (2006, methodology): “The endpoint measured was death or lung transplantation and median (range) follow up was 38 (1-54) months.”
• An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. (2014, background): “A midthigh muscle cross-sectional area (MTCSA), 70 cm(2) (A) (5), a low fat-free mass index (FFMI) defined as an FFMI , 16 kg/m(2) in men and , 15 kg/m(2) in women (B) (1), and a reduced quadriceps strength defined as a quadriceps strength (kg) to body mass index (BMI, kg/m(2)) ratio , 120% (C) (7)”